SILANES
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

SILANES Trademark

Serial Number: 75176361 • Registration: 2241440

SILANES is a trademark filed by Laboratorios Silanes S.A. DE C.V. on October 3, 1996. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Laboratorios Silanes S.A. DE C.V. (12 trademarks)

Amores No. 1304
Mexico DF CP03100 , MX

Entity Type: 03

Trademark Details

Filing Date

October 3, 1996

Registration Date

April 27, 1999

Published for Opposition

September 22, 1998

Goods & Services

pharmaceuticals, namely, injectable solutions, tablets, pills and capsules for adults and children, oral suspension, medicated syrup and ointment, all for treatment as a cough suppressant, and expectorant, [ activity against anaerobic bacteria, Trichomona vaginalis, Entamoeba histolytica, and giardia lamblia, ] as an antifungal agent for treatment of Oropharyngeal and esophageal candidiasis, [ candidial urinary tract infections, peritonitis and systemic candidal infections, candidemia, disseminated candidiasis and pneumonia, cryptococcal meningitis, candidal genital tract infections, ] as an analgesis anti-inflamatory non steroidal inhibitor of prostaglandin synthetase, [ analgesic and minor tranquilizer, active immunization against tetanus, peripheral neuritis, neuralgias, peripheral neuritis, neuralgias and haematopoietic, antifungal agent for treatment of systemic blastomycosis, histoplasmosis paracoccidloidomycosis, fungal infection of the gastrointestinal tract and tinea infections of the skin, and nails, sulphonylurea and biguanide, hipoglycaemic agent, activity against trichomonas vaginalis, entamoeba histolytica and Giardia lamblia, anaerobic bacteria, ] histamine H1-receptor antagonist and prophylactic treatment of asthma, and treatment of allergic conditions such as rhinitis and conjuntivitis,[ analgesic, ] anti-inflamatory non steroidal, for inhibiting prostaglanding synthetase, [ analgesic, anti-inflammatory non steroidal, inhibitor of prostaglandin synthetase ] and muscle relaxant, analgesic, antipyretic, [ sulphonylurea hipoglycaemic agent, for inhibiting as an angiotensin-converting enzyme, treatment of congestive heart failure and asymptomatic left ventricular dysfunction, diuretic treatment of congestive heart failure, hypertension, cardiac, renal hepatogenic oedema, peripheral neuritis, neuralgias and analgesic, ] a broad spectrum antibiotic, effective against a wide range of Gram positive and Gram negative aerobic and anaerobic bacterias, [ histamin H2-receptor antagonist in the treatment of gastric an duodenal ulcer, Zollinger-Ellison syndrome, iron deficiency and anemia for children or adults, ] anixolytic, anticonvulsant, sedative, muscle relaxant, [ histamine H2-receptor antagonist in the treatment of gastric and duodenal ulcer Zollinger-Ellison syndrome, ] multivitamin treatment and prevention of vitamin B1-B6-B12 deficiency, [ tricyclic antidepressant, treatment of nocturnal enuresis in children, inhibits angiotensin-converting enzyme, ] treatment of hypertension and congestive heart failure, treatment and prevention of vitamic C deficiency, treatment and prevention of seborrhoea and dandruff, analgesic no narcotic

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 23, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 23, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 23, 2022 REAP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 16, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 16, 2020 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
May 21, 2019 NA89
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
May 21, 2019 RNL2
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
May 21, 2019 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 20, 2019 APRE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 16, 2019 TCCA
TEAS SECTION 8 & 9 RECEIVED
Apr 16, 2019 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Apr 27, 2018 REM2
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Feb 26, 2009 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Feb 26, 2009 89AG
TEAS SECTION 8 & 9 RECEIVED
Feb 19, 2009 E89R
CASE FILE IN TICRS
Jul 13, 2007 CFIT
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Dec 30, 2005 8.OK
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Oct 27, 2005 815F
TEAS SECTION 8 RECEIVED
Oct 27, 2005 ES8R
REGISTERED-PRINCIPAL REGISTER
Apr 27, 1999 R.PR
NOTICE OF ALLOWANCE CANCELLED
Mar 15, 1999 IUCN
NOA MAILED - SOU REQUIRED FROM APPLICANT
Dec 15, 1998 NOAM
Sec. 1(B) CLAIM DELETED
Oct 29, 1998 1.BD
PUBLISHED FOR OPPOSITION
Sep 22, 1998 PUBO
NOTICE OF PUBLICATION
Aug 21, 1998 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 20, 1998 CNSA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 20, 1998 ZZZX
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jul 17, 1998 JURT
EX PARTE APPEAL-INSTITUTED
Jul 17, 1998 EXPI
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 9, 1998 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 18, 1998 CRFA
FINAL REFUSAL MAILED
Nov 18, 1997 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 14, 1997 CRFA
NON-FINAL ACTION MAILED
Apr 12, 1997 CNRT
ASSIGNED TO EXAMINER
Apr 8, 1997 DOCK